EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content

Alzheimer's disease patients temporal lobe vs. healthy control temporal l lobe

Differential gene expression in the frontal lobe of Alzheimer's disease (AD) patients was calculated using the FPKM (Fragments Per Kilobase of exon per Million fragments mapped) ratio between AD patients and healthy control for every gene identified as expressed by Cufflinks. Top 30 highest and 30 lowest significantly expressed genes (P-Value<0.05 and passing false discovery rate threshold) are shown here.
Author
RNA Sequencing
Parent Experiment
Comparisons (3) | Samples (36)

RNA sequencing profiling comparing temporal lobe samples collected from both Alzheimer disease patients (n=6) and from healthy controls (n=6). Brain tissues samples were obtained from post-mortem human brains. 

In this experiment, gene expression profiles of the frontal lobe and the whole brain were also tested, but were not included in LifeMap analysis. 

Alzheimer's disease patients temporal lobe vs. healthy control temporal l lobe